Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$1.91 USD
-0.04 (-2.05%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $1.92 +0.01 (0.52%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SSKN 1.91 -0.04(-2.05%)
Will SSKN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SSKN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SSKN
Why Fast-paced Mover Strata Skin Sciences (SSKN) Is a Great Choice for Value Investors
Despite Fast-paced Momentum, Strata Skin Sciences (SSKN) Is Still a Bargain Stock
SSKN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SSKN
STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and ...
12 Health Care Stocks Moving In Tuesday's After-Market Session
Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE)
SSKN Gains Approval Expansion for Excimer Laser Treatments | SSKN Stock News
Strata Skin Sciences AMA accepted revision to CPT codes